A Phase 4 interventional study of Lidocaine HCl 2% . and Lidocaine HCl 1% in Fractures of the Distal Radius, sponsored by HaEmek Medical Center, Israel. Completed at 1 site in Israel. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2020-02-17.
Sponsored by HaEmek Medical Center, Israel · Phase 4, Interventional, and Treatment
The purpose of this study is to Prove that injection of 15 to 20 mL of lidocaine 1% into the fracture site (Hematoma block) is more effective in terms of pain relieving then injection of 10 mL of lidocaine 2%, and equally safe in terms of complications, for closed reduction of distal radius fractures.
HaEmek Medical Center, Israel is the lead sponsor of 237 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Lidocaine HCl 2% (200mg/10ml) 10 ml.
Drug: Lidocaine HCl 2% .
Lidocaine HCl 1% (100mg/10ml) 15-20 ml.
Drug: Lidocaine HCl 1%
comparison of different dosages of drug
Also known as: ESRACAIN
comparison of different dosages of drug
Also known as: ESRACAIN
This study will be measured effective in terms of pain relieving with Visual Analog Scale.
Time frame: 1 year
This study will be measured safe in terms of complications to injection.
Number of Participants with Adverse Events as a Measure of Safety and Tolerability.
Time frame: 1 year
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Lidocaine
HaEmek Medical Center, Israel →